» Articles » PMID: 27435310

Accumulation of Arachidonic Acid-containing Phosphatidylinositol at the Outer Edge of Colorectal Cancer

Abstract

Accumulating evidence indicates that cancer cells show specific alterations in phospholipid metabolism that contribute to tumour progression in several types of cancer, including colorectal cancer. Questions still remain as to what lipids characterize the outer edge of cancer tissues and whether those cancer outer edge-specific lipid compositions emerge autonomously in cancer cells. Cancer tissue-originated spheroids (CTOSs) that are composed of pure primary cancer cells have been developed. In this study, we aimed to seek out the cancer cell-autonomous acquisition of cancer outer edge-characterizing lipids in colorectal cancer by analysing phospholipids in CTOSs derived from colorectal cancer patients with matrix-assisted laser desorption/ionization (MALDI)-imaging mass spectrometry (IMS). A signal at m/z 885.5 in negative ion mode was detected specifically at the surface regions. The signal was identified as an arachidonic acid (AA)-containing phosphatidylinositol (PI), PI(18:0/20:4), by tandem mass spectrometry analysis. Quantitative analysis revealed that the amount of PI(18:0/20:4) in the surface region of CTOSs was two-fold higher than that in the medial region. Finally, PI(18:0/20:4) was enriched at the cancer cells/stromal interface in colorectal cancer patients. These data imply a possible importance of AA-containing PI for colorectal cancer progression, and suggest cells expressing AA-containing PI as potential targets for anti-cancer therapy.

Citing Articles

Branched-chain amino acids and specific phosphatidylinositols are plasma metabolite pairs associated with menstrual pain severity.

Sato A, Yuyama K, Ichiba Y, Kakizawa Y, Sugiura Y Sci Rep. 2025; 15(1):3194.

PMID: 39863658 PMC: 11762980. DOI: 10.1038/s41598-025-87415-8.


The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer.

Glibetic N, Bowman S, Skaggs T, Weichhaus M Int J Mol Sci. 2024; 25(19).

PMID: 39408832 PMC: 11477048. DOI: 10.3390/ijms251910503.


Disrupted gut microecology after high-dose I therapy and radioprotective effects of arachidonic acid supplementation.

Lu G, Gao D, Jiang W, Yu X, Tong J, Liu X Eur J Nucl Med Mol Imaging. 2024; 51(8):2395-2408.

PMID: 38561516 PMC: 11178657. DOI: 10.1007/s00259-024-06688-9.


The colibactin-producing alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.

de Oliveira Alves N, Dalmasso G, Nikitina D, Vaysse A, Ruez R, Ledoux L Gut Microbes. 2024; 16(1):2320291.

PMID: 38417029 PMC: 10903627. DOI: 10.1080/19490976.2024.2320291.


Functional mass spectrometry imaging maps phospholipase-A2 enzyme activity during osteoarthritis progression.

Fan X, Young R, Sun A, Hamilton B, Nedunchezhiyan U, Crawford R Theranostics. 2023; 13(13):4636-4649.

PMID: 37649605 PMC: 10465221. DOI: 10.7150/thno.86623.


References
1.
Kawashima M, Iwamoto N, Kawaguchi-Sakita N, Sugimoto M, Ueno T, Mikami Y . High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci. 2013; 104(10):1372-9. PMC: 7656533. DOI: 10.1111/cas.12229. View

2.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

3.
Morita Y, Sakaguchi T, Ikegami K, Goto-Inoue N, Hayasaka T, Hang V . Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression. J Hepatol. 2013; 59(2):292-9. DOI: 10.1016/j.jhep.2013.02.030. View

4.
Schulze A, Harris A . How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012; 491(7424):364-73. DOI: 10.1038/nature11706. View

5.
Kunisawa J, Arita M, Hayasaka T, Harada T, Iwamoto R, Nagasawa R . Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut. Sci Rep. 2015; 5:9750. PMC: 4464255. DOI: 10.1038/srep09750. View